Literature DB >> 4205946

Development of a purified cholera toxoid. II. Preparation of a stable, antigenic toxoid by reaction of purified toxin with glutaraldehyde.

R S Rappaport, G Bonde, T McCann, B A Rubin, H Tint.   

Abstract

Evidence is presented which confirms that cholera toxoids obtained by reaction of purified toxin with Formalin possess the ability to partially reactivate both in vivo and in vitro. At the same time, conditions are presented for the preparation of stable, antigenic cholera toxoids by reaction of purified toxin with glutaraldehyde. Treatment of purified cholera toxin with approximately 200 mol of glutaraldehyde per mol of toxin at pH 7.8 reproducibly resulted in the preparation of toxoids which: (i) possessed less than 20 bluing doses per 100 mug; (ii) did not reactivate in vivo or in vitro; (iii) precipitated with, and neutralized antitoxin; (iv) elevated prolonged serum antitoxin in immunized rabbits; (v) protected immunized guinea pigs against toxin skin challenge; and (vi) lent themselves to enhanced antigenicity by means of an in situ adjuvant system which may be suitable for man. Acrylamide gel electrophoresis and molecular sieve chromatography of a series of glutaraldehyde-derived toxoids suggested that the reaction products consisted of monomeric and polymeric species and that the proportion of higher-molecular-weight species was determined by the relative concentrations of toxin and glutaraldehyde. The results suggested a relationship between complete and irreversible elimination of toxicity and the formation of higher-molecular-weight toxoids.

Entities:  

Mesh:

Substances:

Year:  1974        PMID: 4205946      PMCID: PMC414802          DOI: 10.1128/iai.9.2.304-317.1974

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  30 in total

1.  Stimulation of glycogenolysis by purified cholera exotoxin in disrupted cells.

Authors:  P D Zieve; N F Pierce; W B Greenough
Journal:  Johns Hopkins Med J       Date:  1971-12

2.  Stimulation of glycerol production in fat cells by cholera toxin.

Authors:  M Vaughan; N F Pierce; W B Greenough
Journal:  Nature       Date:  1970-05-16       Impact factor: 49.962

3.  Experimental studies on cholera immunization. II. Evidence for protective antitoxic immunity mediated by serum antibodies as well as local antibodies.

Authors:  J Holmgren; A Andersson; G Wallerstrom; O Ouchterlony
Journal:  Infect Immun       Date:  1972-05       Impact factor: 3.441

4.  Protection against experimental cholera by antitoxin.

Authors:  N F Pierce; E A Kaniecki; R S Northrup
Journal:  J Infect Dis       Date:  1972-12       Impact factor: 5.226

5.  Adjuvant effect of cholera enterotoxin on the immune response of the mouse to sheep red blood cells.

Authors:  R S Northrup; A S Fauci
Journal:  J Infect Dis       Date:  1972-06       Impact factor: 5.226

6.  Pathogenesis of experimental cholera: choleragen-induced rat foot edema; a method of screening anticholera drugs.

Authors:  R A Finkelstein; J J Jehl; A Goth
Journal:  Proc Soc Exp Biol Med       Date:  1969-12

7.  Experimental canine cholera. II. Production by cell-free culture filtrates of Vibrio cholerae.

Authors:  R B Sack; C C Carpenter
Journal:  J Infect Dis       Date:  1969-02       Impact factor: 5.226

8.  Properties and enzymatic activities of papain insolubilized with glutaraldehyde.

Authors:  E F Jansen; A C Olson
Journal:  Arch Biochem Biophys       Date:  1969-01       Impact factor: 4.013

9.  A permeability factor (toxin) found in cholera stools and culture filtrates and its neutralization by convalescent cholera sera.

Authors:  J P Craig
Journal:  Nature       Date:  1965-08-07       Impact factor: 49.962

10.  Development of a purified cholera toxoid. I. Purification of toxin.

Authors:  R S Rappaport; B A Rubin; H Tint
Journal:  Infect Immun       Date:  1974-02       Impact factor: 3.441

View more
  11 in total

1.  Antigenicity of purified glutaraldehyde-treated cholera toxoid administered orally.

Authors:  M M Levine; T P Hughes; C R Young; S O'Donnell; J P Craig; H P Holley; E J Bergquist
Journal:  Infect Immun       Date:  1978-07       Impact factor: 3.441

2.  Simple method for purifying choleragenoid, the natural toxoid of Vibrio cholerae.

Authors:  J J Mekalanos; R J Collier; W R Romig
Journal:  Infect Immun       Date:  1977-06       Impact factor: 3.441

3.  Development of a purified cholera toxoid. III. Refinements in purification of toxin and methods for the determination of residual somatic antigen.

Authors:  R S Rappaport; W A Pierzchala; G Bonde; T McCann; B A Rubin
Journal:  Infect Immun       Date:  1976-09       Impact factor: 3.441

4.  Antitoxic immunity in experimental cholera: protection, and serum and local antibody responses in rabbits after enteral and parenteral immunization.

Authors:  J Holmgren; A M Svennerholm; O Ouchterlony; A Anderson; G Walletström; U Westerberg-Berndtsson
Journal:  Infect Immun       Date:  1975-12       Impact factor: 3.441

5.  Preparation of a purified antigenic cholera toxoid.

Authors:  R Germanier; E Fürer; S Varallyay; T M Inderbitzin
Journal:  Infect Immun       Date:  1976-06       Impact factor: 3.441

6.  Effect of chemical and heat inactivation on the antigenicity and immunogenicity of Vibrio cholerae.

Authors:  S J Cryz; E Fürer; R Germanier
Journal:  Infect Immun       Date:  1982-10       Impact factor: 3.441

7.  Antigenic specificity of neutralizing antibody to cholera toxin.

Authors:  J W Peterson; K E Hejtmancik; D E Markel; J P Craig; A Kurosky
Journal:  Infect Immun       Date:  1979-06       Impact factor: 3.441

8.  Flagella-induced immunity against experimental cholera in adult rabbits.

Authors:  R J Yancey; D L Willis; L J Berry
Journal:  Infect Immun       Date:  1979-07       Impact factor: 3.441

9.  Induction of a mucosal antitoxin response and its role in immunity to experimental canine cholera.

Authors:  N F Pierce; W C Cray; B K Sircar
Journal:  Infect Immun       Date:  1978-07       Impact factor: 3.441

10.  Arousal of mucosal secretory immunoglobulin A antitoxin in rats immunized with Escherichia coli heat-labile enterotoxin.

Authors:  F A Klipstein; R F Engert; J D Clements
Journal:  Infect Immun       Date:  1982-09       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.